WILMINGTON, Del. – Directors are selling OmniVision too cheaply through an unfair process to China-based Hua Capital Management, for $1.9 billion or $29.75 per share, shareholders claim in Chancery Court.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.

